Norwest 18: A Groundbreaking $4 Billion Fund Close
Norwest 18, a recent fund closed by the global investment firm Norwest, has successfully raised $4 billion, making it the largest fundraising initiative in the company’s 65 years. This closure elevates the total assets under management (AUM) for Norwest to an impressive $18 billion. The new fund is designed to facilitate venture capital and growth equity investments within the realms of technology, healthcare, and consumer sectors primarily in the US, India, and Israel.
Focus on Diverse Sectors
The portfolio of Norwest comprises notable companies such as Babylist, Gong, Monogram Health, OfBusiness, VAST Data, Vuori, and YipitData. Since launching Norwest 17 in April 2024, the firm has completed over 87 investments. Additionally, it has aided more than 30 portfolio companies in realizing liquidity events through public listings and strategic acquisitions.
Public Offerings and Acquisitions
Among the portfolio companies that have made public offerings during this timeframe are Amagi Media Labs and Swiggy from India, along with BillionToOne, MBX Biosciences, and Omada Health. Several companies have also been acquired, including Avetta by EQT, AbsenceSoft by Luminate Capital Partners, Ouro Medicines by Gilead Sciences, Qualified by Salesforce, tvScientific by Pinterest, and Veza by ServiceNow.
Expanding Investment Focus
Norwest is broadening its investment interests to encompass areas like next-generation financial infrastructure, physical and voice AI, agentic cybersecurity, technology-enabled industrial and aerospace sectors, and healthcare AI. Recent financial infrastructure investments include entities like Beltic, Rain, and Stablecore, while Coval, Generalist AI, and LlamaIndex are part of its AI systems and agentic technologies portfolio.
Cybersecurity and Industrial Investments
In the field of cybersecurity, the firm has invested in Above Security, ORION Security, Red Access, and Zenity. Its ventures in industrial and aerospace domains include East Range Group, Padmini VNA, JJG Aerospace, and Raghu Vamsi Aerospace Group.
Commitment to Healthcare Innovation
Norwest’s investments in healthcare firms such as Infinx, Matchpoint Therapeutics, Rezo Therapeutics, Tokaido Health, and Vitalize Care are focused on enhancing technology and AI integration within drug discovery, clinical workflows, and healthcare delivery.
Support Beyond Funding
Beyond mere funding, Norwest ensures that portfolio companies receive strategic advisory and operational support. The firm has extended its Portfolio Success platform by enhancing its Senior Advisor Network, incorporating Operating Executives, and introducing the Norwest Operator Collective and Norwest Kinetic.
A Legacy of Investment
Established in 1961, Norwest has invested in over 750 companies and currently collaborates with more than 275 businesses within its venture and growth equity portfolio. The firm operates offices in Menlo Park and San Francisco in California, as well as Mumbai in India and Tel Aviv in Israel.